NCT03158883 2021-10-20
UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients
University of California, Davis
Phase EARLY_PHASE1 Completed
University of California, Davis
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Massachusetts General Hospital